These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31560640)

  • 1. Dose-Rate-Dependent PU.1 Inactivation to Develop Acute Myeloid Leukemia in Mice Through Persistent Stem Cell Proliferation After Acute or Chronic Gamma Irradiation.
    Ojima M; Hirouchi T; Etani R; Ariyoshi K; Fujishima Y; Kai M
    Radiat Res; 2019 Dec; 192(6):612-620. PubMed ID: 31560640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia.
    Brown N; Finnon R; Manning G; Bouffler S; Badie C
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():48-54. PubMed ID: 26520372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterisation of murine acute myeloid leukaemia induced by 56Fe ion and 137Cs gamma ray irradiation.
    Steffen LS; Bacher JW; Peng Y; Le PN; Ding LH; Genik PC; Ray FA; Bedford JS; Fallgren CM; Bailey SM; Ullrich RL; Weil MM; Story MD
    Mutagenesis; 2013 Jan; 28(1):71-9. PubMed ID: 22987027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML.
    O'Brien G; Cruz-Garcia L; Zyla J; Brown N; Finnon R; Polanska J; Badie C
    Carcinogenesis; 2020 Aug; 41(8):1104-1112. PubMed ID: 31646336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia.
    Olme CH; Finnon R; Brown N; Kabacik S; Bouffler SD; Badie C
    Leuk Res; 2013 Oct; 37(10):1374-82. PubMed ID: 23806234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemogenesis in heterozygous PU.1 knockout mice.
    Genik PC; Vyazunova I; Steffen LS; Bacher JW; Bielefeldt-Ohmann H; McKercher S; Ullrich RL; Fallgren CM; Weil MM; Ray FA
    Radiat Res; 2014 Sep; 182(3):310-5. PubMed ID: 25076114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML.
    Verbiest T; Bouffler S; Nutt SL; Badie C
    Carcinogenesis; 2015 Apr; 36(4):413-9. PubMed ID: 25750172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
    Brown NL; Finnon R; Bulman RA; Finnon P; Moody J; Bouffler SD; Badie C
    Leuk Res; 2011 Jan; 35(1):126-32. PubMed ID: 20638124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells.
    Olme CH; Brown N; Finnon R; Bouffler SD; Badie C
    Mutat Res; 2013 Aug; 756(1-2):119-26. PubMed ID: 23665297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.
    Houston IB; Kamath MB; Schweitzer BL; Chlon TM; DeKoter RP
    Exp Hematol; 2007 Jul; 35(7):1056-68. PubMed ID: 17588474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
    Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
    Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
    Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.
    Metcalf D; Dakic A; Mifsud S; Di Rago L; Wu L; Nutt S
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1486-91. PubMed ID: 16432184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular kinetics of hematopoietic cells with
    Etani R; Ojima M; Ariyoshi K; Fujishima Y; Kai M
    Int J Radiat Biol; 2020 Sep; 96(9):1119-1124. PubMed ID: 32658559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem/progenitor cell differentiation towards myeloid lineage is modulated by LIGHT/LIGHT receptor signaling.
    Chen W; Lv X; Liu C; Chen R; Liu J; Dai H; Zou GM
    J Cell Physiol; 2018 Feb; 233(2):1095-1103. PubMed ID: 28422285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
    Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
    Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.
    Anderson KL; Smith KA; Perkin H; Hermanson G; Anderson CG; Jolly DJ; Maki RA; Torbett BE
    Blood; 1999 Oct; 94(7):2310-8. PubMed ID: 10498603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.